1ST HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY OF FORMOTEROL CONCENTRATIONS IN THE LOW-PICOGRAM-PER-MILLILITER RANGE

被引:18
作者
VANDENBERG, BTJ
PORTIER, EJG
VANDENBERG, M
BRAAT, MCP
VANBOXTEL, CJ
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT CLIN PHARMACOL,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT PULMONOL,1105 AZ AMSTERDAM,NETHERLANDS
关键词
FORMOTEROL; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; ELECTROCHEMICAL DETECTION; HUMANS;
D O I
10.1097/00007691-199404000-00015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A method for the assay of plasma concentrations of the long-acting beta2-adrenoceptor agonist, formoterol is described. This method, in which high-performance liquid chromotography is used with electrochemical detection, enables, for the first time, pharmacokinetic and pharmacodynamic research with this drug. After column extraction of plasma samples, the eluent is injected on the chromatographic system. Retention times of formoterol and the internal standard, bromo-formoterol, were 5.6 and 10 min, respectively. Our results show that this is a sensitive and reproducible method with a very low limit of detection (20 pg/ml), which creates the possibility of measuring concentrations in a range achievable in humans.
引用
收藏
页码:196 / 199
页数:4
相关论文
共 11 条
[1]  
CRANE J, 1989, LANCET, V1, P917
[2]   FORMOTEROL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE [J].
FAULDS, D ;
HOLLINGSHEAD, LM ;
GOA, KL .
DRUGS, 1991, 42 (01) :115-137
[3]   QUANTITATIVE-DETERMINATION OF THE BETA-ADRENOCEPTOR STIMULANT FORMOTEROL IN URINE BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
KAMIMURA, H ;
SASAKI, H ;
HIGUCHI, S ;
SHIOBARA, Y .
JOURNAL OF CHROMATOGRAPHY, 1982, 229 (02) :337-345
[4]   DETERMINATION OF SALBUTAMOL IN HUMAN-PLASMA WITH BIMODAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND A ROTATED DISK AMPEROMETRIC DETECTOR [J].
OOSTERHUIS, B ;
VANBOXTEL, CJ .
JOURNAL OF CHROMATOGRAPHY, 1982, 232 (02) :327-334
[5]   PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF TERBUTALINE BRONCHODILATION IN ASTHMA [J].
OOSTERHUIS, B ;
BRAAT, MCP ;
ROOS, CM ;
WEMER, J ;
VANBOXTEL, CJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (04) :469-475
[6]  
OOSTERHUIS B, 1987, PROGR HPLC, V2, P95
[7]  
PATESSIO A, 1991, EUR RESPIR J, V4, P196
[8]   CASE-CONTROL STUDY OF PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW-ZEALAND, 1977-81 [J].
PEARCE, N ;
GRAINGER, J ;
ATKINSON, M ;
CRANE, J ;
BURGESS, C ;
CULLING, C ;
WINDOM, H ;
BEASLEY, R .
THORAX, 1990, 45 (03) :170-175
[9]   PROLONGED PROTECTION AGAINST METHACHOLINE-INDUCED BRONCHOCONSTRICTION BY THE INHALED BETA-2-AGONIST FORMOTEROL [J].
RAMSDALE, EH ;
OTIS, J ;
KLINE, PA ;
GONTOVNICK, LS ;
HARGREAVE, FE ;
OBYRNE, PM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (05) :998-1001
[10]   PLASMA ASSAY OF SALBUTAMOL BY MEANS OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH AMPEROMETRIC DETERMINATION USING A LOOP COLUMN FOR INJECTION OF PLASMA EXTRACTS - APPLICATION TO THE EVALUATION OF SUBCUTANEOUS ADMINISTRATION OF SALBUTAMOL [J].
TAMISIERKAROLAK, L ;
DELHOTALLANDES, B ;
JOLLIETRIANT, P ;
MILLIEZ, J ;
JANNET, D ;
BARRE, J ;
FLOUVAT, B .
THERAPEUTIC DRUG MONITORING, 1992, 14 (03) :243-248